NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis
Canada - TSX-V:NLH - CA66980G1090 - Common Stock
0.35 CAD
+0.01 (+2.94%)
We assign a fundamental rating of 4 out of 10 to NLH. NLH was compared to 15 industry peers in the Health Care Providers & Services industry. NLH has an average financial health and profitability rating. NLH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year NLH has reported negative net income.
In the past year NLH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NLH reported negative net income in multiple years.
In the past 5 years NLH always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of NLH (0.49%) is comparable to the rest of the industry.
NLH has a Return On Equity of 0.62%. This is in the better half of the industry: NLH outperforms 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.34%, NLH is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.49% | ||
| ROE | 0.62% | ||
| ROIC | 3.34% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 0.41%, NLH perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
NLH's Profit Margin has declined in the last couple of years.
NLH has a Operating Margin (3.04%) which is in line with its industry peers.
NLH has a Gross Margin (39.13%) which is in line with its industry peers.
In the last couple of years the Gross Margin of NLH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.04% | ||
| PM (TTM) | 0.41% | ||
| GM | 39.13% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
2. Health
2.1 Basic Checks
NLH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
NLH has more shares outstanding than it did 1 year ago.
NLH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NLH is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.87 indicates that NLH is not in any danger for bankruptcy at the moment.
NLH's Altman-Z score of 3.87 is amongst the best of the industry. NLH outperforms 86.67% of its industry peers.
The Debt to FCF ratio of NLH is 2.32, which is a good value as it means it would take NLH, 2.32 years of fcf income to pay off all of its debts.
NLH's Debt to FCF ratio of 2.32 is amongst the best of the industry. NLH outperforms 86.67% of its industry peers.
NLH has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
NLH has a better Debt to Equity ratio (0.04) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 2.32 | ||
| Altman-Z | 3.87 |
ROIC/WACC0.42
WACC7.89%
2.3 Liquidity
NLH has a Current Ratio of 0.82. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.82, NLH perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
NLH has a Quick Ratio of 0.82. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
NLH has a Quick ratio (0.82) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.38% over the past year.
Measured over the past years, NLH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.19% on average per year.
Looking at the last year, NLH shows a quite strong growth in Revenue. The Revenue has grown by 8.63% in the last year.
Measured over the past years, NLH shows a quite strong growth in Revenue. The Revenue has been growing by 8.16% on average per year.
EPS 1Y (TTM)15.38%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-311.54%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%26.55%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NLH is valued a bit cheaper than 66.67% of the companies in the same industry.
66.67% of the companies in the same industry are more expensive than NLH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.63 | ||
| EV/EBITDA | 15.38 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NLH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:NLH (9/23/2025, 7:00:00 PM)
0.35
+0.01 (+2.94%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.98%
Ins Owner ChangeN/A
Market Cap30.56M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.78 | ||
| P/FCF | 15.63 | ||
| P/OCF | 15.36 | ||
| P/B | 1.18 | ||
| P/tB | 27.26 | ||
| EV/EBITDA | 15.38 |
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY6.4%
OCF(TTM)0.02
OCFY6.51%
SpS0.45
BVpS0.3
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.49% | ||
| ROE | 0.62% | ||
| ROCE | 4.39% | ||
| ROIC | 3.34% | ||
| ROICexc | 3.59% | ||
| ROICexgc | 267.42% | ||
| OM | 3.04% | ||
| PM (TTM) | 0.41% | ||
| GM | 39.13% | ||
| FCFM | 5.02% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
F-Score5
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 2.32 | ||
| Debt/EBITDA | 0.53 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 5.13 | ||
| Cash Conversion | 92.26% | ||
| Profit Quality | 1214.21% | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 3.87 |
F-Score5
WACC7.89%
ROIC/WACC0.42
Cap/Depr(3y)4.23%
Cap/Depr(5y)2.79%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-311.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%26.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.27%
FCF growth 3Y-14.49%
FCF growth 5Y17.9%
OCF growth 1Y-37.45%
OCF growth 3Y-13.97%
OCF growth 5Y17.73%